Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development

Overview

Journal Plants (Basel)

Date 2025 Jan 8

PMID 39771262

Authors

Eugenia S Mardanova

Egor A Vasyagin

Nikolai V Ravin

Affiliations

Soon will be listed here.

Abstract

The capsid proteins of many viruses are capable of spontaneous self-assembly into virus-like particles (VLPs), which do not contain the viral genome and are therefore not infectious. VLPs are structurally similar to their parent viruses and are therefore effectively recognized by the immune system and can induce strong humoral and cellular immune responses. The structural features of VLPs make them an attractive platform for the development of potential vaccines and diagnostic tools. Chimeric VLPs can be obtained by attaching foreign peptides to capsid proteins. Chimeric VLPs present multiple copies of the antigen on their surface, thereby increasing the effectiveness of the immune response. Recombinant VLPs can be produced in different expression systems. Plants are promising biofactories for the production of recombinant proteins, including VLPs. The main advantages of plant expression systems are the overall low cost and safety of plant-produced products due to the absence of pathogens common to plants and animals. This review provides an overview of the VLP platform as an approach to developing plant-produced vaccines, focusing on the use of transient expression systems.

Citing Articles

Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines.

Vo D, Trinh K Vaccines (Basel). 2025; 13(2).

PMID: 40006737 PMC: 11860421. DOI: 10.3390/vaccines13020191.

References

Fischer R, Buyel J . Molecular farming - The slope of enlightenment. Biotechnol Adv. 2020; 40:107519. DOI: 10.1016/j.biotechadv.2020.107519. View

Siebenga J, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen R . Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol. 2007; 81(18):9932-41. PMC: 2045401. DOI: 10.1128/JVI.00674-07. View

Marsian J, Fox H, Bahar M, Kotecha A, Fry E, Stuart D . Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nat Commun. 2017; 8(1):245. PMC: 5557999. DOI: 10.1038/s41467-017-00090-w. View

Matic S, Masenga V, Poli A, Rinaldi R, Milne R, Vecchiati M . Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J. 2012; 10(4):410-21. DOI: 10.1111/j.1467-7652.2011.00671.x. View

Shanmugaraj B, Bulaon C, Phoolcharoen W . Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production. Plants (Basel). 2020; 9(7). PMC: 7411908. DOI: 10.3390/plants9070842. View

Kushnir N, Streatfield S, Yusibov V . Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine. 2012; 31(1):58-83. PMC: 7115575. DOI: 10.1016/j.vaccine.2012.10.083. View

Pillet S, Aubin E, Trepanier S, Bussiere D, Dargis M, Poulin J . A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Clin Immunol. 2016; 168:72-87. DOI: 10.1016/j.clim.2016.03.008. View

Pillet S, Aubin E, Trepanier S, Poulin J, Yassine-Diab B, Ter Meulen J . Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial. NPJ Vaccines. 2018; 3:3. PMC: 5780465. DOI: 10.1038/s41541-017-0043-3. View

Mardanova E, Takova K, Toneva V, Zahmanova G, Tsybalova L, Ravin N . A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles. Biotechnol Lett. 2020; 42(11):2441-2446. DOI: 10.1007/s10529-020-02995-x. View

10.

Rafique S, Jabeen Z, Pervaiz T, Rashid F, Luo S, Xie L . Avian infectious bronchitis virus (AIBV) review by continent. Front Cell Infect Microbiol. 2024; 14:1325346. PMC: 10875066. DOI: 10.3389/fcimb.2024.1325346. View

11.

Ryabchevskaya E, Granovskiy D, Evtushenko E, Ivanov P, Kondakova O, Nikitin N . Designing Stable Antigens with a View to Recombinant Anthrax Vaccine Development. Pharmaceutics. 2022; 14(4). PMC: 9025368. DOI: 10.3390/pharmaceutics14040806. View

12.

Matic S, Rinaldi R, Masenga V, Noris E . Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol. 2011; 11:106. PMC: 3248878. DOI: 10.1186/1472-6750-11-106. View

13.

Mor T, Moon Y, Palmer K, Mason H . Geminivirus vectors for high-level expression of foreign proteins in plant cells. Biotechnol Bioeng. 2002; 81(4):430-7. DOI: 10.1002/bit.10483. View

14.

Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen C . An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine. 2008; 26(15):1846-54. PMC: 2744496. DOI: 10.1016/j.vaccine.2008.01.053. View

15.

Fernandez-San Millan A, Ortigosa S, Hervas-Stubbs S, Corral-Martinez P, Segui-Simarro J, Gaetan J . Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J. 2008; 6(5):427-41. DOI: 10.1111/j.1467-7652.2008.00338.x. View

16.

Kundig T, Klimek L, Schendzielorz P, Renner W, Senti G, Bachmann M . Is The Allergen Really Needed in Allergy Immunotherapy?. Curr Treat Options Allergy. 2015; 2(1):72-82. PMC: 4335088. DOI: 10.1007/s40521-014-0038-5. View

17.

Mardanova E, Kotlyarov R, Stuchinskaya M, Nikolaeva L, Zahmanova G, Ravin N . High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors. Int J Mol Sci. 2022; 23(24). PMC: 9779006. DOI: 10.3390/ijms232415684. View

18.

Peyret H, Ponndorf D, Meshcheriakova Y, Richardson J, Lomonossoff G . Covalent protein display on Hepatitis B core-like particles in plants through the in vivo use of the SpyTag/SpyCatcher system. Sci Rep. 2020; 10(1):17095. PMC: 7555512. DOI: 10.1038/s41598-020-74105-w. View

19.

Duvenage L, Hitzeroth I, Meyers A, Rybicki E . Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides. J Virol Methods. 2013; 191(1):55-62. DOI: 10.1016/j.jviromet.2013.03.028. View

20.

Arzola L, Chen J, Rattanaporn K, Maclean J, McDonald K . Transient co-expression of post-transcriptional gene silencing suppressors for increased in planta expression of a recombinant anthrax receptor fusion protein. Int J Mol Sci. 2011; 12(8):4975-90. PMC: 3179146. DOI: 10.3390/ijms12084975. View